Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06559059 · ClinicalTrials.gov registry record
Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs
A clinical trial of Lung Cancer (Diagnosis) and Prostate Cancer (Diagnosis), sponsored by NYU Langone Health.
- Recruiting
- Registry status
- 1,800
- Enrollment target
- 5
- Study locations
NCT06559059: Recruiting study of Lung Cancer (Diagnosis) and Prostate Cancer (Diagnosis), sponsored by NYU Langone Health.
NCT06559059 is a study of Lung Cancer (Diagnosis) and Prostate Cancer (Diagnosis) that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 1,800 participants, below the 4,282-participant average among 6 other Lung Cancer (Diagnosis) trials with a reported enrollment target (58% lower). The trial reports 5 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06559059, a study of Lung Cancer (Diagnosis) and Prostate Cancer (Diagnosis), is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- 1,800 participants
- Enrollment target
- 5
- Study locations
Study Summary
The objective of the pragmatic trial to test the effectiveness of an existing, ongoing clinical service, the VA National TeleOncology program (NTO), a multilevel telehealth population health management program. The primary aims are to study the intervention and determine its effectiveness on telehealth engagement, clinical quality, and healthcare cost outcomes across personal characteristics.
Primary Outcome
Telehealth utilization among Veterans with cancer will be measured through raw telehealth visit counts.
Conditions Studied
Study Locations (5)
New York
- VA New York Harbor Healthcare System - Brooklyn - Brooklyn
- VA New York Harbor Healthcare System - St. Albans Community Living Center - Jamaica
- VA New York Harbor Health Care System - Manhattan - New York
- VA New York Harbor Healthcare System - Harlem Community Center - New York
- VA New York Harbor Healthcare System - Staten Island Community Clinic - Staten Island
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,800 participants |
| Start Date | 2024-06-18 |
| Est. Completion | 2027-07-31 |
What NCT06559059 shows while recruiting
NCT06559059 is an observational study that tracks outcomes without assigning an intervention. Its 1,800 participants enrollment target places it among the larger protocols in the corpus, below the 4,282-participant average among 6 other Lung Cancer (Diagnosis) trials with a reported enrollment target (58% lower).
The record links to 4 conditions, with Lung Cancer (Diagnosis) appearing as the primary indexed condition, and to 0 interventions.
NCT06559059 lists 5 locations in 1 state (New York).
Frequently Asked Questions
What is clinical trial NCT06559059 about?
NCT06559059 is a clinical study titled "Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs". The objective of the pragmatic trial to test the effectiveness of an existing, ongoing clinical service, the VA National TeleOncology program (NTO), a multilevel telehealth population health management program. The primary aims are to study the intervention and determine its effectiveness on telehea...
What is the current status of trial NCT06559059?
This trial is currently recruiting. The enrollment target is 1,800 participants. The study started on 2024-06-18. Estimated completion is 2027-07-31.
What conditions does trial NCT06559059 study?
This clinical trial studies the following conditions: Lung Cancer (Diagnosis), Prostate Cancer (Diagnosis), Colorectal Cancer (Diagnosis), Breast Cancer Diagnosis.
Who is sponsoring clinical trial NCT06559059?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06559059 being conducted?
This trial has 5 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer (Diagnosis)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
RECRUITING · NA
-
SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer Survivors
RECRUITING · NA
-
Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots
RECRUITING
-
Telehealth Collaborative Care Model (CoCM) in Lung Cancer
RECRUITING · NA
-
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
RECRUITING
-
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03630055 · 1,800 participants · Phase 3
Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion
- NCT04475640 · 1,800 participants · NA
Cancer Genetic Testing in Ethnic Populations
- NCT04980794 · 1,800 participants · NA
The Happy Families Project: Testing the Effectiveness of a Conflict Resolution Program for Families
- NCT05258656 · 1,800 participants · NA
Childhood Activities Nutrition and Development Oversight
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI